Can bioinformatics help trace the steps from gene mutation to disease?
Citation Manager Formats
Make Comment
See Comments
![Loading Loading](https://n.neurology.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this issue of Neurology, Minassian et al. expand their earlier contributions on Lafora’s disease using new informational technology to seek homologies between regions of the EMP2A gene product laforin and other proteins of known biological activity.1 This direct application of genomics to a clinical problem may clarify a mechanism of pathogenesis and provide rationale for future therapies. Genomics uses 1) DNA sequence data and 2) computational systems to store, access and analyze the data. Together, these constitute the new field of bioinformatics.
Gene sequence data were historically obtained from messenger RNA transcripts of well-known proteins (such as hemoglobin and ovalbumin). The Human Genome Project (HGP) provides DNA sequences for “new” genes without known function, based on nucleotide patterns characteristic of gene structure. The path from these newly discovered genes to the biological activities of their products requires a multifaceted approach.2
Sequence data from the HGP also allows a correlation to be made between a change in genetic structure (a mutation, deletion, or recombination) and the occurrence of disease. Bioinformatics will not explain how a gene is regulated or how changes in regulation induce disease. However, new technology to define patterns of gene transcription (a key to gene expression) is rapidly developing (table 1).
- In this window
- In a new window
Applications for bioinformatics in research and medicine
Broad access to genomic information is now possible through highly refined user-friendly software. BLAST (Basic Local Alignment Search Tool), for example, is a sensitive and time effective program for detection of biologically significant relationships between genetic molecular structure and …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Association of Neurofilament Light With the Development and Severity of Parkinson Disease
Dr. Rodolfo Savica and Dr. Parichita Choudhury
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathyS. Bohlega, S. N. Abu-Amero, S. M. Wakil et al.Neurology, May 10, 2004 -
Articles
Mutation spectrum and predicted function of laforin in Lafora’s progressive myoclonus epilepsyB.A. Minassian, L. Ianzano, M. Meloche et al.Neurology, August 08, 2000 -
Clinical/Scientific Notes
Updated nomenclature for human and mouse neurofibromatosis type 1 genesCorina Anastasaki, Lu Q. Le, Robert A. Kesterson et al.Neurology: Genetics, July 26, 2017 -
Article
Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4Lekha Pandit, Laura M. Cox, Chaithra Malli et al.Neurology: Neuroimmunology & Neuroinflammation, November 04, 2020